Speaker Details
David Redfern
Chief Strategy Officer, GlaxoSmithKline
David was appointed Chief Strategy Officer in May 2008 and is responsible for proactive exploration of new business opportunities, strategic planning and dermatology. In addition to his current role, he was appointed Chairman of the Board of ViiV Healthcare Ltd. in April 2011. He is a member of the Corporate Executive Team. Previously, he was Senior Vice President, Northern Europe with responsibility for managing GSK's pharmaceutical businesses in
David joined the company in 1994 from PricewaterhouseCoopers, where he managed a portfolio of audit clients and corporate transactions. He began his career with GSK as Corporate Accounts Manager, and spent 4 years in the Corporate Development team before being appointed Finance Director of European Pharmaceuticals in 1999. He was appointed Senior Vice President & Area Director, Central Europe in 2003, where he successfully led the Central Europe markets through their transition into the EU, and
David has a Bachelor of Science degree from
